Kit Contents：
|
Components |
50 tests/kit |
|
RT-PCR reaction buffer |
915 μL × 1 tube |
|
RT-PCR enzyme mix |
85 μL × 1 tube |
|
Positive control |
100 μL × 1 tube |
|
Negative control |
100 μL × 1 tube |
Product Description：
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
This kit is used for in vitro qualitative detection of novel coronavirus 2019-nCoV in respiratory specimens including oropharyngeal swab, sputum, bronchoalveolar lavage fluid and nasopharyngeal swab. Primer sets and FAM labeled probe are designed for specific detection of ORFlab gene of 2019-nCoV, VIC labeled probe for N gene of 2019-nCoV. Human RNase P gene extracted concurrently with the test sample provides an internal control to validate nucleic extraction procedure and reagent integrity. Probe targeting human RNase P gene is labeled with CY5.
Product Features：
1.It is able to test the Delta variant of novel coronavirus
2.High sensitivity. It can conduct accurate testing of less than 300 copies/ ml
3.High specificity. it adopts hot start technology to simultaneously test two independent genes ORFlab gene and N gene of the virus, realizing double positive test
4.Short time. It takes only 1 hour to complete the sample rapid detection
5.High tolerance to impurities. With a highly optimized buffer system, it can realize compatible tolerance to a variety of interfering
